Utilization of Optical Coherence Tomography in the Diagnosis of Intraplaque Hemorrhage Causing Severe Basilar Artery Stenosis
Stroke. 2024 Mar 11. doi: 10.1161/STROKEAHA.123.045940. Online ahead of print.NO ABSTRACTPMID:38465587 | DOI:10.1161/STROKEAHA.123.045940 (Source: Atherosclerosis)
Source: Atherosclerosis - March 11, 2024 Category: Cardiology Authors: Di Li Tao Tang Teng Hu Aline M Thomas Shen Li Source Type: research
Age and duration of hypertension are associated with carotid artery tortuosity
ConclusionCarotid artery tortuosity is a relatively common carotid artery disease. The incidence of carotid artery tortuosity may increase with age and the duration of hypertension. The consumption of antihypertensive drugs may reduce the incidence of carotid artery tortuosity. (Source: Frontiers in Neurology)
Source: Frontiers in Neurology - March 11, 2024 Category: Neurology Source Type: research
ABO Blood Type and Thromboembolic Complications after Intracerebral Hemorrhage: an exploratory analysis
Non-O blood types are known to be associated with thromboembolic complications (TECs) in population-based studies. TECs are known drivers of morbidity and mortality in intracerebral hemorrhage (ICH) patients, yet the relationships of blood type on TECs in this patient population are unknown. We sought to explore the relationships between ABO blood type and TECs in ICH patients. (Source: Journal of Stroke and Cerebrovascular Diseases)
Source: Journal of Stroke and Cerebrovascular Diseases - March 11, 2024 Category: Neurology Authors: Natasha Ironside, Kara Melmed, Ching-Jen Chen, Nisha Dabhi, Setareh Omran, Soojin Park, Sachin Agarwal, E. Sander Connolly, Jan Claassen, Eldad A. Hod, David Roh Source Type: research
Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study
To the Editor In their population-based cohort study using Taiwan ’s National Health Insurance Research Database, Tsai et al report no excess risk of intracranial hemorrhage (ICH) associated with treatment compared with no treatment with non-vitamin K antagonist oral anticoagulants (NOACs) in patients with acute ischemic stroke receiving intravenous alteplase. W e applaud the authors’ efforts to build on the evidence on the safety of thrombolysis in patients receiving NOACs; however, we wonder about potential issues of exposure and outcome misclassification producing results that are biased toward the null hypothesis. ...
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study
To the Editor We read with interest the nationwide population-based cohort study with meta-analysis by Tsai et al. The study findings showed that patients who received non-vitamin K antagonist oral anticoagulants (NOACs) before a stroke, compared with those receiving warfarin and those without oral anticoagulant treatment (non-OAC), did not experience a higher risk of intracranial hemorrhage (ICH), major bleeding events, or mortality when treated with intravenous alteplase for acute ischemic stroke. In comparison with the active comparator (warfarin group), the odds ratios (ORs) were 0.88 (95% CI, 0.32-2.40) for ICH, 0.82 ...
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
